Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Introgen Therapeutics (INGN)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for INGN as compared to
Top Competitors
Biotechnology
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
1.11M
LOW
EBITDA
►
-22.6M
AVG
Net Income
►
-24.3M
AVG
Revenue Growth
►
73.4%
AVG
Operating Margin
►
-2634.3%
LOW
Net Margin
►
-2193.9%
LOW
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-5.29
Current Ratio
►
1.04
LOW
Quick Ratio
►
1.04
LOW
Interest Coverage Ratio
►
-36.5
AVG
Book Value Per Share
►
-0.303
Cash Per Share
►
0.760
Loading...
STOCK SUMMARY
Open
0.00
Day Range
0.05
-
0.10
52 Week Range
0.05
-
3.55
Volume
0
Avg Volume (3 mo)
190K
Shares Outstanding
8.28M
Market Cap
2.65M
VALUATION
Price to Earnings (P/E)
►
-0.109
Price to Book (P/B)
►
-1.05
Price to Sales (P/S)
►
2.39
AVG
Return on Assets (ROA)
►
-87.8%
AVG
Return on Equity (ROE)
►
-181.2%
AVG
EV/EBITDA
►
-0.700
Dividend Yield
0%
AVG
OWNERSHIP
Net Insider Buying 3mo
0%
Net Insider Buying 6mo
0%
Net Insider Buying 1yr
0%
Held by insiders
145.1%
Held by institutions
3.3%
No Sales Breakout Data.